BIOKURIS

Curileum

The company develops novel therapies and small molecule drugs to restore gastrointestinal tissue health for patients with bowel cancer and inflammatory bowel disease.

Gut Wealth

This company manufactures digestive health supplements, including postbiotic capsules and liquid sachets, for individuals suffering from irritable bowel syndrome and digestive discomfort.

Evinature

The company develops and sells herbal nutraceuticals and tailored gut health protocols for patients with inflammatory bowel disease and gastrointestinal conditions.

Kiwi Biosciences

The company develops digestive enzyme supplements to help individuals with irritable bowel syndrome and food intolerances break down problematic carbohydrates.

Boomerang Medical

This company develops bioelectric neuromodulation technology to treat autoimmune diseases, including inflammatory bowel disease, for patients with ulcerative colitis and Crohn's disease.

EnteroBiotix

This biopharmaceutical company develops orally administered microbial therapeutics for patients with gastrointestinal diseases, including irritable bowel syndrome and blood cancers.

Biomesense

This company develops automated biosensors and analytics software for continuous gut microbiome tracking for clinical researchers, biotechnology firms and pharmaceutical organisations.

GutCRINE

This company develops microbiome-derived pharmabiotics to treat metabolic and age-related disorders including obesity and type-2 diabetes for patients with chronic diseases.